The significant style rotation from growth to value over the opening months of this year has attracted widespread attention, as for the first time for a decade, market leadership has switched from growth to value stocks.
This makes our progress report on our suggestion that value, represented by our proxy Imperial Brands, might outperform growth, represented by Rentokil Initial, over a five-year period from May 2020 particularly timely. Looking back one year to the first-year update in May 2021, Imperial had, despite a poor start, modestly outperformed Rentokil, delivering a total return of 4.6% compared to 2.3% over the period 6 May 2020 to 5 May 2021. This was despite the fact that Rentokil, with particular help from their Hygiene division, delivered stronger financial metrics through the pandemi...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes